Skip to Content

Labetuzumab

https://www.medicalbillingandcodingcertification.net/web/image/product.template/261294/image_1920?unique=778ea14
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy[1].

2,382.00 € 2382.0 EUR 2,382.00 €

2,382.00 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days